Dr Lal PathLabs Q2 net profit jumps 27 pc to Rs 194 cr

Summarized by AI ⓘ

What is the story about?

New

Delhi, Nov 4 (PTI) Dr Lal PathLabs on Wednesday said its consolidated profit after tax (PAT) increased 27.39 per cent to Rs 193.9 crore for the September quarter on the back of a rise in revenues.

The diagnostics firm reported a profit after tax (PAT) of Rs 152.2 crore in the July-September period of the last fiscal year, according to a regulatory filing.

Its total revenue increased to Rs 908.2 crore for the period under review, as against Rs 755.4 crore in the year-ago period, Dr Lal PathLabs said.

The company’s total expenses also rose to Rs 647.6 crore in the July-September period, from Rs 551.8 crore a year earlier.

Shares of Dr Lal PathLabs ended at Rs 2,027 apiece on the BSE, 5.1 per cent higher from the previous close. PTI TRB HVA

Dr Lal PathLabs Q2 net profit jumps 27 pc to Rs 194 cr

Related Stories

More stories you might like

Dabur Q2 profit up 12 pc at Rs 498 cr, revenue rises to Rs 3,563 cr

Honasa Consumer Q2 profit up 86.7% to Rs 73.2 cr, revenue up 36% to Rs 731 cr

Emami Q2 PAT up nearly 2 pc at Rs 145 cr, revenue up 36 pc to Rs 1,087 cr

Titan Q2 net profit rises over 2x to Rs 2,393 cr, sales up 23.5 pc

Aurobindo Pharma posts 32.5 pc rise in Q2 net profit on record revenue

Mafatlal Industries Q2 PAT falls 50.3 pc to Rs 11 cr

Q2 Results Live Updates: M&M revenue up 27.1%; Shilpa Medicare net profit up 79.5%

Biocon Q2 net profit falls 57.3 pc to Rs 56.7 cr

Evonile Pharma posts Rs 77.54 cr net loss in Q2

Q2 Results Live Updates: Biocon net profit falls 57.4%; Dr Lal PathLabs EBITDA up 24.9%

AI Generated